Sherbrooke Park Advisers »

Krystal Biotech shares owned by Sherbrooke Park Advisers

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Sherbrooke Park Advisers from 13F filings

Historical chart of Sherbrooke Park Advisers investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Sherbrooke Park Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Sherbrooke Park Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $771k 4.3k 177.93

More positions owned by Sherbrooke Park Advisers

Johnson & Johnson (JNJ)
Apple (AAPL)
Lennar Corp Cl A (LEN)
Ssr Mining (SSRM)
Smartsheet Com Cl A (SMAR)
Dow (DOW)
Gxo Logistics Incorporated Common Stock (GXO)
Royal Gold (RGLD)
Philip Morris International (PM)
Archer Daniels Midland Company (ADM)
Kraft Heinz (KHC)
Masco Corporation (MAS)
Reynolds Consumer Prods (REYN)
Etsy (ETSY)
Microsoft Corporation (MSFT)

View all positions for Sherbrooke Park Advisers

Top funds holding Krystal Biotech

FMR
venBio Select Advisor
Vanguard Group
BlackRock
Redmile Group
Frazier Life Sciences Management
Jennison Associates
T. Rowe Price Associates
Dimensional Fund Advisors
Geode Capital Management
Lord, Abbett & Co
Ikarian Capital
Susquehanna International
Goldman Sachs Group
Nuveen Asset Management

View all funds holding Krystal Biotech